Relevant conflicts of interest/financial disclosures: Nothing to report. Mandar Jog served on scientific advisory boards for Allergan (Chair 2008, 2009), Novartis (participant 2008, 2009), Biovail (participant 2009) and Teva (Chair/participant 2008, 2009). He has received travel grants for conference proceedings: Teva 2008; 2009 and Novartis 2009 and also received honoraria from Novartis, Allergan, Biovail Pharma, and Teva Neuroscience, Merz pharmaceutical, Boehringer Ingelheim, Prestwick pharmaceuticals, and GlaxoSmithKline. Full financial disclosures and author roles may be found in the online version of this article.
Carbamazepine responsive dysphagia—A variant of paroxysmal kinesigenic dyskinesia?†
Version of Record online: 14 APR 2011
Copyright © 2010 Movement Disorder Society
Volume 26, Issue 7, pages 1356–1358, June 2011
How to Cite
Kumar, H., South, A. and Jog, M. (2011), Carbamazepine responsive dysphagia—A variant of paroxysmal kinesigenic dyskinesia?. Mov. Disord., 26: 1356–1358. doi: 10.1002/mds.23541
- Issue online: 20 JUN 2011
- Version of Record online: 14 APR 2011
Additional Supporting Information may be found in the online version of this article.
|MDS_23541_sm_suppvideo1.wmv||1612K||Supporting Video 1|
|MDS_23541_sm_suppvideo2.wmv||1300K||Supporting Video 2|
|MDS_23541_sm_suppvideo3.wmv||870K||Supporting Video 3|
|MDS_23541_sm_suppvideo4.wmv||753K||Supporting Video 4|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.